422 related articles for article (PubMed ID: 25352017)
1. Implementation of the CRISPR-Cas9 system in fission yeast.
Jacobs JZ; Ciccaglione KM; Tournier V; Zaratiegui M
Nat Commun; 2014 Oct; 5():5344. PubMed ID: 25352017
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference.
Zhao Y; Boeke JD
Nucleic Acids Res; 2020 Jun; 48(10):5788-5798. PubMed ID: 32374858
[TBL] [Abstract][Full Text] [Related]
3. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
Yan F; Wang W; Zhang J
Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
[No Abstract] [Full Text] [Related]
5. Expanding the Biologist's Toolkit with CRISPR-Cas9.
Sternberg SH; Doudna JA
Mol Cell; 2015 May; 58(4):568-74. PubMed ID: 26000842
[TBL] [Abstract][Full Text] [Related]
6. 5S rRNA Promoter for Guide RNA Expression Enabled Highly Efficient CRISPR/Cas9 Genome Editing in
Zheng X; Zheng P; Zhang K; Cairns TC; Meyer V; Sun J; Ma Y
ACS Synth Biol; 2019 Jul; 8(7):1568-1574. PubMed ID: 29687998
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
8. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
Fu Y; Reyon D; Joung JK
Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
[TBL] [Abstract][Full Text] [Related]
9. An Agrobacterium-delivered CRISPR/Cas9 system for high-frequency targeted mutagenesis in maize.
Char SN; Neelakandan AK; Nahampun H; Frame B; Main M; Spalding MH; Becraft PW; Meyers BC; Walbot V; Wang K; Yang B
Plant Biotechnol J; 2017 Feb; 15(2):257-268. PubMed ID: 27510362
[TBL] [Abstract][Full Text] [Related]
10. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
12. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
13. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
Xu X; Chemparathy A; Zeng L; Kempton HR; Shang S; Nakamura M; Qi LS
Mol Cell; 2021 Oct; 81(20):4333-4345.e4. PubMed ID: 34480847
[TBL] [Abstract][Full Text] [Related]
14. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of stringent PAM recognition by CRISPR-C2c1 in complex with sgRNA.
Wu D; Guan X; Zhu Y; Ren K; Huang Z
Cell Res; 2017 May; 27(5):705-708. PubMed ID: 28374750
[No Abstract] [Full Text] [Related]
16. Programmable RNA recognition and cleavage by CRISPR/Cas9.
O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
[TBL] [Abstract][Full Text] [Related]
17. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
[TBL] [Abstract][Full Text] [Related]
18. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
Mandal PK; Ferreira LM; Collins R; Meissner TB; Boutwell CL; Friesen M; Vrbanac V; Garrison BS; Stortchevoi A; Bryder D; Musunuru K; Brand H; Tager AM; Allen TM; Talkowski ME; Rossi DJ; Cowan CA
Cell Stem Cell; 2014 Nov; 15(5):643-52. PubMed ID: 25517468
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA Expression.
Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Takayama K; Tachibana M; Mizuguchi H
Biol Pharm Bull; 2017; 40(3):272-277. PubMed ID: 28250269
[TBL] [Abstract][Full Text] [Related]
20. Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs.
Port F; Bullock SL
Nat Methods; 2016 Oct; 13(10):852-4. PubMed ID: 27595403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
